BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23522498)

  • 1. Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
    Gredler V; Mader S; Schanda K; Hegen H; Di Pauli F; Kuenz B; Deisenhammer F; Berger T; Reindl M; Lutterotti A
    J Neurol Sci; 2013 May; 328(1-2):77-82. PubMed ID: 23522498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels.
    Nakashima I; Takahashi T; Cree BA; Kim HJ; Suzuki C; Genain CP; Vincent T; Fujihara K; Itoyama Y; Bar-Or A
    J Clin Neurosci; 2011 Jul; 18(7):997-8. PubMed ID: 21565508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies.
    Chang KH; Lyu RK; Chen CM; Wu YR; Chang HS; Huang CC; Kuo HC; Chu CC; Hsu WC; Ro LS
    Mult Scler; 2013 Mar; 19(3):299-307. PubMed ID: 22829325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
    Lechner C; Baumann M; Hennes EM; Schanda K; Marquard K; Karenfort M; Leiz S; Pohl D; Venkateswaran S; Pritsch M; Koch J; Schimmel M; Häusler M; Klein A; Blaschek A; Thiels C; Lücke T; Gruber-Sedlmayr U; Kornek B; Hahn A; Leypoldt F; Sandrieser T; Gallwitz H; Stoffels J; Korenke C; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):897-905. PubMed ID: 26645082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.
    Pellkofer HL; Krumbholz M; Berthele A; Hemmer B; Gerdes LA; Havla J; Bittner R; Canis M; Meinl E; Hohlfeld R; Kuempfel T
    Neurology; 2011 Apr; 76(15):1310-5. PubMed ID: 21482945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
    Mangat P; Ravindran J; Cleland L; Limaye V
    Clin Rheumatol; 2008 Dec; 27 Suppl 2():S67-9. PubMed ID: 18560921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
    Waters P; Jarius S; Littleton E; Leite MI; Jacob S; Gray B; Geraldes R; Vale T; Jacob A; Palace J; Maxwell S; Beeson D; Vincent A
    Arch Neurol; 2008 Jul; 65(7):913-9. PubMed ID: 18625857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
    Ringelstein M; Harmel J; Distelmaier F; Ingwersen J; Menge T; Hellwig K; Kieseier B; Mayatepek E; Hartung HP; Kuempfel T; Aktas O
    Mult Scler; 2013 Oct; 19(11):1544-7. PubMed ID: 23886825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.
    Carnero Contentti E; Hryb JP; Morales S; Gomez A; Chiganer E; Di Pace JL; Lessa C; Perassolo M
    J Neurol Sci; 2017 Feb; 373():134-137. PubMed ID: 28131170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica IgG status in acute partial transverse myelitis.
    Scott TF; Kassab SL; Pittock SJ
    Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
    Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
    Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinally extensive transverse myelitis.
    Tobin WO; Weinshenker BG; Lucchinetti CF
    Curr Opin Neurol; 2014 Jun; 27(3):279-89. PubMed ID: 24792338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
    Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
    Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
    Hyun JW; Kim SH; Huh SY; Kim W; Yun J; Joung A; Sato DK; Fujihara K; Kim HJ
    Mult Scler; 2015 May; 21(6):710-7. PubMed ID: 25305252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection.
    Heerlein K; Jarius S; Jacobi C; Rohde S; Storch-Hagenlocher B; Wildemann B
    J Neurol Sci; 2009 Jan; 276(1-2):184-6. PubMed ID: 18805556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.